Dr. Fitch Discusses Dose Escalation of Radiation in Prostate Cancer

Video

Dwight L. Fitch, MD, Radiation Oncologist, 21st Century Oncology in Bradenton, Florida, discusses dose modifications for radiation therapy in patients with prostate cancer.

Dwight L. Fitch, MD, Radiation Oncologist, 21st Century Oncology in Bradenton, Florida, discusses dose modifications for radiation therapy in patients with prostate cancer.

Over the last 10 years, the dose of radiation for prostate cancer has gone from 70 Gy to 79-81 Gy. This dose increase lowers PSA failure while increasing prostate cancer control; however, it remains unclear whether it improves survival, Fitch notes. Additionally, the increased dose results in added toxicity.

A study presented at the 2014 ASTRO Annual Meeting attempted to address these concern. Overall, the analysis showed that patients could be treated at a few fractions under the maximum tolerated dose to help decrease toxicities, without compromising PSA control and survival, Fitch says.

Related Videos
Ricardo D. Parrondo, MD, hematologist/oncologist, Mayo Clinic
Ilyas Sahin, MD
Raj Singh, MD
Jaime R. Merchán, MD, professor, co-leader, Translational and Clinical Oncology Research Program, director, Phase 1 Clinical Trials Program, Department of Medicine, Division of Medical Oncology, the University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center
Saad J. Kenderian, MB, CHB
Tycel Phillips, MD
Minesh Mehta, MD
Shivaani Kummar, MBBS, FACP, Margaret and Lester DeArmond Endowed Chair of Cancer Research, Professor and Division Head, Division of Hematology/Medical Oncology, Oregon Health & Science University School of Medicine; co-director, Center for Experimental Therapeutics, co-deputy director, Knight Cancer Institute
Andre Goy, MD
Wenxin (Vincent) Xu, MD,